Concepedia

Sophie Corvaisier

SC

Statistics

Publications

23

Citations

853

H-Index

16

Active since

2003

Affiliations

Université de Caen Normandie(Current)

Centre d'Etudes et de Recherche sur le Médicament de Normandie

Normandie Université

Inserm

Centre National de la Recherche Scientifique

Sophie Corvaisier is an author at Université de Caen Normandie specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2003–2022

23

Publications

23

KiSS‐1 and GPR54 Genes are Co‐Expressed in Rat Gonadotrophs and Differentially Regulated <i>In Vivo</i> by Oestradiol and Gonadotrophin‐Releasing Hormone

Nicolas Richard, G. Galmiche, Sophie Corvaisier et al. · Journal of Neuroendocrinology · 2008 · 140 citations · Full text

, , +12

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Cédric Lecoutey, Damien Hédou, Thomas Fréret et al. · Proceedings of the National Academy of Sciences · 2014 · 119 citations · Full text

, , +17

Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT<sub>4</sub>R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride

Christophe Rochais, Cédric Lecoutey, Florence Gaven et al. · Journal of Medicinal Chemistry · 2015 · 117 citations · Full text

, , +17

Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment

Thomas Adnet, Anne‐Claire Groo, Céline Picard et al. · Pharmaceutics · 2020 · 76 citations · Full text

, , +17

The design of donecopride, a dual 5-HT4R agonist/AChE inhibitor with potential interest for AD treatment

Cédric Lecoutey, Damien Hédou, Thomas Fréret et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2014 · 39 citations

, , +17

1–5 of 23